Drug intelligence / Profile preview

sappanchalcone

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical, Intraperitoneal
01

Overview

Sappanchalcone is a natural chalcone derivative, primarily isolated from the heartwood of *Caesalpinia sappan*, that is being investigated for its potent anticancer properties against non-small cell lung cancer (NSCLC). Its mechanism of action is multifaceted, involving the induction of oxidative stress and the accumulation of reactive oxygen species (ROS), which leads to DNA damage and the activation of the DNA damage response. Sappanchalcone also perturbs ion homeostasis by downregulating the mechanosensitive ion channel PIEZO1 and inducing intracellular calcium elevation. This calcium signaling triggers endoplasmic reticulum (ER) stress pathways, specifically through the phosphorylation and activation of IRE1α and PERK. These combined effects result in the upregulation of P21 and GADD45α, the suppression of the CDK1/Cyclin B1 complex, and the induction of G2/M phase cell cycle arrest and apoptosis in cancer cells.

Other names
SC
02

Targets

ERN1 (Inositol-requiring enzyme 1 alpha)EIF2AK3 (Pkr-like endoplasmic reticulum kinase)CDK1 (Cyclin-dependent kinase 1)CCNB1 (Cyclin B1)PIEZO1 (Piezo-type mechanosensitive ion channel component 1)DNA

Beyond the preview

Go deeper on sappanchalcone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sappanchalcone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call